Titre:
  • Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD)
Auteur:Vukusic, Sandra; Brassat, David; de Seze, Jerome; Izquierdo, Guillermo; Lysandropoulos, Andreas; Moll, Wibe; Vanopdenbosch, Ludo; Arque, Maria Jesus; Kertous, Mehdi; Rufi, Pascal; Oreja-Guevara, Celia
Informations sur la publication:Multiple Sclerosis and Related Disorders, 29, page (7-14)
Statut de publication:Publié, 2019-04
Sujet CREF:Neurologie
Pharmacologie
Mots-clés:Alemtuzumab
Induction therapy
Infusion-associated reaction (IAR)
Methylprednisolone treatment
Multiple sclerosis
Rash
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2211-0348
info:doi/10.1016/j.msard.2019.01.019
info:pii/S2211034819300197
info:scp/85059864855